Back to Search Start Over

Nanoparticles for intravascular applications : physicochemical characterization and cytotoxicity testing

Authors :
Rudolf Urbanics
Maya Juenet
Jan Zaloga
Janos Szebeni
László Dézsi
Isabelle Texier
Ruth Prassl
Jens Baumgartner
Christoph Alexiou
Fabrice Navarro
Didier Letourneur
Harald Mangge
Danielle Franke
Damien Faivre
Iwona Cicha
Josbert M. Metselaar
Acarilia Eduardo da Silva
Jasmin Matuszak
Cédric Chauvierre
Gunter Almer
Biomaterials Science and Technology
Faculty of Science and Technology
Friedrich-Alexander Universität Erlangen-Nürnberg (FAU)
Department of Biomaterials [Potsdam]
Max Planck Institute of Colloids and Interfaces
Max-Planck-Gesellschaft-Max-Planck-Gesellschaft
Laboratoire de Recherche Vasculaire Translationnelle (LVTS (UMR_S_1148 / U1148))
Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Medical University Graz
Commissariat à l'énergie atomique et aux énergies alternatives - Laboratoire d'Electronique et de Technologie de l'Information (CEA-LETI)
Direction de Recherche Technologique (CEA) (DRT (CEA))
Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)
RWTH University Clinic
Semmelweis University [Budapest, Hungary]
Source :
Nanomedicine, Nanomedicine, 11(6), 597-616. Future Medicine Ltd., Nanomedicine, Future Medicine, 2016, 11 (6), pp.597-616. ⟨10.2217/nnm.15.216⟩, Nanomedicine, 2016, 11 (6), pp.597-616. ⟨10.2217/nnm.15.216⟩
Publication Year :
2016

Abstract

Aim: We report the physicochemical analysis of nanosystems intended for cardiovascular applications and their toxicological characterization in static and dynamic cell culture conditions. Methods: Size, polydispersity and ζ-potential were determined in 10 nanoparticle systems including liposomes, lipid nanoparticles, polymeric and iron oxide nanoparticles. Nanoparticle effects on primary human endothelial cell viability were monitored using real-time cell analysis and live-cell microscopy in static conditions, and in a flow model of arterial bifurcations. Results & conclusions: The majority of tested nanosystems were well tolerated by endothelial cells up to the concentration of 100 μg/ml in static, and up to 400 μg/ml in dynamic conditions. Pilot experiments in a pig model showed that intravenous administration of liposomal nanoparticles did not evoke the hypersensitivity reaction. These findings are of importance for future clinical use of nanosystems intended for intravascular applications.

Details

ISSN :
17435889 and 17486963
Database :
OpenAIRE
Journal :
Nanomedicine, Nanomedicine, 11(6), 597-616. Future Medicine Ltd., Nanomedicine, Future Medicine, 2016, 11 (6), pp.597-616. ⟨10.2217/nnm.15.216⟩, Nanomedicine, 2016, 11 (6), pp.597-616. ⟨10.2217/nnm.15.216⟩
Accession number :
edsair.doi.dedup.....140c1dbf7ad7dfe479c01b666a679080
Full Text :
https://doi.org/10.2217/nnm.15.216⟩